1.
Klin Khir
; (7): 54-7, 2016.
Artigo
em Ucraniano
| MEDLINE
| ID: mdl-30256595
RESUMO
Erysipelas (PB) a serious disease that is accompanied by severe complications and high lethality. The immunological investigations were carry out in 51 patients who were treated at the clinic for erysipelas with an immunomodulator application. Marked changes in the indices of phagocytic activity of monocytes (PHAM) and the cytokine profile in patients with erysipelas were note. Application in complex treatment of immunomodulator give the positive effect on the indices of PHAM.